11 November 2013

"Greek pharmaceutical companies adhere strictly to international standards", states Professor Machairas

The fact that the Greek Pharmaceutical Industry meets high production standards was highlighted by Professor Panagiotis Machairas, Biopharmaceutics & Pharmacokinetics, National & Kapodistrian University of Athens, in his speech at the 1st Greek National Conference on "Crisis Management in Healthcare".

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

09 November 2013

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

An appeal to increase pharmaceutical expenditure in order to ensure the patients's access to reliable and qualitative treatments was made by the leaders of the Pharma sector on Saturday, November 9, at the 1st Greek National Conference on "Crisis Management in the Pharmaceutical Sector".

ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler<sup>®</sup>

31 October 2013

ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler®

ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.

ELPEN - The leading greek pharmaceutical company
Search